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httpcense.Abstract Background: Associated symptoms of bronchogenic carcinoma other than chest com-
plaints like dysphagia are rarely demonstrated in literature regarding prevalence, cause–effect rela-
tionship and proper management plan. Gastrointestinal motility disorder as a cause of dysphagia in
lung cancer is incompletely understood. This prospective preliminary study aims to ﬁnd out the
prevalence and different aetiologic mechanisms for dysphagia among lung cancer patients using
oesphagoscopy and oesphageal manometry.
Patients and methods: All lung cancer patients with dysphagia admitted in the Cancer Institute,
Assiut University during the year 2010–2012 were included in the study. All patients were subjected
to oesophagoscopy and oesophagomanometry study.
Results: We collected 165 cases of bronchogenic carcinoma during the study period. Dysphagia
was diagnosed in 20 cases (12.1%) regardless the stage of malignancy. Four separate dysphagia
causes were identiﬁed. Secondary achalasia was diagnosed in 10 cases (50%), whereas enlarged
mediastinal lymph nodes and candidal oesphagitis in 4 cases each (20%), and chemoradiotherapy
in 2 cases (10%).
Conclusions: Dysphagia associated with bronchogenic carcinoma is not uncommon and should
be asked for and documented in all cases if present. Secondary achalasia is the commonest mech-
anism of dysphagia based on oesphagoscopy and manometry. Further large sample multicenteric06368362.
com (W.A. Hassan).
e Egyptian Society of Chest
g by Elsevier
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436 W.A. Hassan et al.studies are needed to outline a proper management plan for dysphagia in lung cancer in collabora-
tion with the gastroenterology medical and surgical departments.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Table 1 Different causes of dysphagia among the study
group.
Causes of dysphagia Number %
1 Enlarged mediastinal lymph nodes 4 20
2 Secondary achalasia 10 50
3 Dysphagia after chemoradiotherapy 2 10
4 Dysphagia due to candidal infections 4 20
Total 20 100
Figure 1 CT scan of the chest showing multiple mediastinal
lymphadenopathy obliterating the oesphageal lumen (secondary
to poorly differentiated squamous cell carcinoma of the left lung).Introduction
Cough, hemoptysis, chest pain and weight loss are classic
symptoms of bronchogenic carcinoma. Dysphagia is rarely
mentioned in this symptom complex [1]. Gastrointestinal
motility disorder as a cause of dysphagia in lung cancer is incom-
pletely understood. There probably is a functional aetiology in
rare cases. It may appear because of a reﬂex disturbance [2].
For the most part, an organic agent with underlying
mechanical factors causes the dysphagia. First, compression
of the pharynx and upper oesophagus by enlarged, tumour-
bearing lymph nodes in the neck may be a cause. Second,
and most common of all, deviation and compression of the
oesophagus by involved lymph nodes in the mediastinum,
with, and possibly without ﬁxation of the oesophageal wall,
produce dysphagia. Tumour erosion into and through the
oesophageal wall forming a tracheoesophageal ﬁstula occurs.
Occasionally, it becomes an unfortunate late complication of
radiotherapy [3].
In this study we tried to ﬁnd different aetiologies for dys-
phagia among lung cancer patients using oesphagoscopy and
manometry.
Patients and methods
All lung cancer patients with dysphagia admitted in the Cancer
Institute, Assiut University during the year 2010–2012 were in-
cluded in the study. A total of 20 patients, 14 patients (70%)
were men and 6 patients (30%) were women. The median
age of the patients was 55 ± 8 years. An assessment respira-
tory questionnaire containing respiratory symptoms, chest
x-ray, bronchoscopy, CT reports and ﬁnal pathological
diagnosis was ﬁlled for each patient. All CT examinations
were performed with a Somatom Plus S CT unit (Siemens,
Erlangen, Germany). All patients had gone through upper
gastrointestinal endoscopy before the manometry study.
Manometry was always performed by the internal medicine
doctor, assisted by one of specially trained nurses. High
Resolution Manometry was performed through nasal intro-
duction of solid state catheter with 32 transducer (pressure
sensor) spaced 1 cm to the oesophagus and stomach [4]. The
system is plotting graphs with high resolution colour topogra-
phy and pressure wave plotting as well. This software was
produced by Medical Measurement System (MMS) Enscheda,
The Netherlands.
Results
This prospective study was conducted between April 2010 and
May 2012 in the Assiut Cancer Institute, Assiut University,
Assiut, Egypt. We collected 165 cases of bronchogenic carci-
noma during the study period. Dysphagia was diagnosed in
20 cases (12.1%) regardless of the stage of malignancy. Four
separate dysphagia causes were identiﬁed. Secondary achalasiawas diagnosed in 10 cases (50%), whereas enlarged mediastinal
lymph nodes and candidal oesphagitis in 4 cases each (20%),
and chemoradiotherapy in 2 cases (10%) (Table 1). The four
causes, with illustrative case histories, are discussed in detail
below.
Dysphagia due to enlarged mediastinal lymph nodes
Case No. 1
A 65 year old male patient presented with features of worsen-
ing airﬂow obstruction, he had dysphagia for solids for
3 months. Post contrast CT chest showed central large soft tis-
sue tumour mass lesion with enlarged multiple mediastinal
lymph nodes obliterating the lumen of the oesphagus
(Fig. 1). Fiberoptic bronchoscopy showed large tumour mass
in the left main bronchus. Bronchoscopic biopsy diagnosed
Figure 2 Diffuse oesphageal spastic ring and Downhill varices
were seen through oesphagoscopy.
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phageal spastic ring was seen through oesphagoscopy
(Fig. 2) and Oesphageal manometry showed ineffective con-
traction (Fig. 3).The patient received two cycles of chemother-
apy and within few days his swallowing was improved.Figure 3 Oesphageal manometryDysphagia due to secondary achalasia
Case No. 2
A previously healthy 66 year old male smoker had a 6 month
history of dyspnoea on exertion associated with wheeze and
nocturnal cough. He also complained of dysphagia for solids
of 3 week duration and a weight loss of 10 kg. Examination re-
vealed 1st degree clubbing of ﬁnger nails, no enlargement of
cervical lymph nodes. He was dyspnoeic and pulmonary func-
tion test showed airﬂow obstruction and later the patient pre-
sented with further symptoms of hoarseness of voice and
haemoptysis. Fiberoptic bronchoscopy biopsy diagnosed squa-
mous cell carcinoma involving left lower lobe bronchus, and
paralysis of the left vocal cord.
Computed tomography (CT) scans of the chest, showed left
central tumour mass lesion with obliteration of the left lower
lobe bronchus causing partial atelectasis and shifting of the
mediastinum to the left side. There was no evidence of local
lymph node enlargement or direct oesophageal involvement
but tumour invasion of the mediastinum was noted (Fig. 4).
Oesophago-gastroscopy examination for dysphagia revealed
no obstructive lesion or mucosal abnormality with the dilated
oesophagus (sluggish motility) with spastic lower oesophageal
sphincter (achalasia) (Fig. 5). Oesophageal manometry sug-
gested achalasia, namely aperistalsis in the oesophageal body,
incomplete relaxation of the lower oesophageal sphincter and
hypertonic lower oesophageal sphincter.
Dysphagia after chemoradiotherapy
Case No. 3
A 61 year old male patient, his past medical history was signif-
icant for brochogenic carcinoma of the left lung, treated with
four cycles of Cisplatin, Etoposide and radiation therapy in
year 2011. The patient was a heavy cigarette smoker. He had
signs of increasingly severe dysphagia of 2 month duration
with vomiting and regurgitation and resulted in the loss ofshowing ineffective contraction.
Figure 4 Oesophago-gastroscopy examination showing dilated
oesophagus (sluggish motility) with spastic upper oesophageal
sphincter (achalasia), and dilated cardiac opening.
Figure 5 CT showing left central tumour mass lesion with
obliteration of the left lower lobe bronchus causing partial
atelectasis and shifting of the mediastinum to the left side.
Figure 6 Ill-deﬁned Lt endobronchial soft tissue mass lesion
obliterating the Lt upper lobar bronchus with subsequent
collapsed Lt upper lobe.
Figure 7 Oesphagoscopy demonstrated diffuse oesophageal
spasm, mid oesophageal ring compression (spastic) from outside
with incompetent cardia.
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increased anteroposterior diameter with symmetrical move-
ment with no other chest abnormality. Abdominal examina-
tion was completely normal. Chest X-ray showed a left
apical mass-like consolidation with a mild perihilar inﬁltrate.
CT showed evidence of an ill-deﬁned left bronchial soft tissue
mass lesion seen obliterating the left upper lobar bronchus
with subsequent collapsed left upper lobe (Fig. 6). Bronchos-
copy showed ﬁxed left vocal cord with a mass originating from
left upper lobe bronchus. Oesophagoscopy demonstrated a
tortuous oesophagus with pooling of secretions. There was
mild increased resistance of lower oesphageal sphincter(LES) on passage of the scope, mid oesophageal ring with
diffuse oesophageal spasm’, there is hiatus hernia with
incompetent cardia (Figs. 7 and 8). This ring did not appear
inﬂammatory or malignant and was located adjacent to the
area previously irradiated 2 years ago during treatment for
the patient’s adenocarcinoma. Oesphagometry showed
inefﬁcient contraction with attacks of oesophageal spasm
and hiatus hernia (Fig. 9).
Figure 8 Oesphagoscopy demonstrated Hiatus hernia.
Figure 10 CT chest showing lung mass with enlarged paratrac-
heal lymph nodes.
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Case No. 4
A man aged 61 with a history of dysphagia and haemoptysis
from 8 weeks. On CT scanning (Fig. 10) right lung mass with
paratracheal lymphadenopathy was seen. Bronchoscopic
biopsy diagnosed large cell carcinoma. OesphagoscopyFigure 9 Oesophagdemonstrated widespread mucosal ulceration throughout the
length of the oesophagus highly suggestive of oesophageal can-
didiasis (Fig. 11). His swallowing improved after oral ﬂuconaz-
ole 100 mg. Oesophageal manometry demonstrated ineffective
motility disorder (Fig. 12).
Discussion
This study highlights the importance of dysphagia as a not
uncommon associated complaint among patients with bron-
chogenic carcinoma. It was diagnosed in 12.1% of cases which
calls for routine asking all cases with bronchogenic carcinoma
about this symptom. Another important practical issueeal Manometry.
Figure 11 Oesphagoscopy showing raised whitish monilial
patches.
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ology medical as well as surgical departments to ﬁnd out the
possible mechanisms of achalasia and to outline proper man-
agement plan on a team approach basis. From this study, four
mechanisms of dysphagia were documented using oesophagos-
copy and oesophagomanometry.
Dysphagia due to mediastinal lymphadenopathy
In this prospective data collection, 20% of our cases had medi-
astinal lymph node enlargement. In lung cancer, direct oespha-
geal invasion may occur with lesions in the left main bronchus
but perioesophageal or subcarinal lymph node deposits are
more often responsible [5]. Anatomically, the subcarinal lymph
nodes, limited in their potential for lateral growth and there-
fore tending to expand posteriorly, are the group most likely
to intrude on the adjacent oesophagus [6]. In addition to aFigure 12 Oesphagdirect physical effect of the enlarged lymph nodes on the pas-
sage of food, both small-cell and non-small-cell carcinomas
have been reported to produce secondary achalasia by interfer-
ing with oesophageal motility [7,8]. Whether this phenomenon
reﬂects direct invasion of the nerve supply of the oesophagus is
unclear. Changes in oesophageal motility have been observed
after pneumonectomy [9], suggesting that nerve damage within
the mediastinum might sometimes be the mechanism in lung
cancer, but another possibility is a paraneoplastic effect on
gastrointestinal motility [10,11].
Dysphagia after chemoradiotherapy
In this case, a patient developed dysphagia probably caused by
oesophageal stricture secondary to radiation and/or chemo-
therapy for a prior lung cancer. Lawson et al. reported the fre-
quency of stricture to be 2.6% and that of stenosis 0.8%
following a 60-Gy dose [12–14]. There have been few isolated
reports on the development of chronic strictures. One paper
noted the occurrence of complete oesophageal obstruction in
a 21 year-old after 14 years of chemo and thoracic radiation
therapy for Hodgkin’s lymphoma [15]. Another study of ﬁve
children concluded that radiation induced strictures may pres-
ent up to 10 years after therapy [16]. It was hypothesized that
children are particularly prone to latent effects given ‘‘that or-
gan development and growth may not be complete at the time
of treatment.’’ This obviously cannot be the case in adults.
Chronic stricture in adults could have been secondary to an
unrelated process such as GERD or hiatal hernia; simply
can be a coincidence. In fact, proton pump inhibitors and
sucralfate are known treatments for both GERD and radiation
induced strictures [17–19].
In a randomized trial of 51 patients, Kaasa et al. reported
that 64% of non small cell lung cancer patients treated with
radiotherapy experienced dysphagia compared to 8% of the
chemotherapy patients 6 weeks after the start of treatment
[12]. The same agents (cisplatin and etoposide) were used ineal manometry.
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treatment.
Maguire et al. [20] similarly found that 75% of their pa-
tients receiving high-dose conformal radiotherapy for lung
cancer (64.2–85.6 Grey) experienced dysphagia. However, the
degree of dysphagia was very variable. On a well-recognized
morbidity scale (RTOG), only 11% had grade 3 acute oesoph-
ageal toxicity (requiring parenteral ﬂuid support). Factors that
seemed to predispose to severe acute toxicity were the existence
of dysphagia before treatment and the use of hyperfractionat-
ed treatment regimens. Chronic oesophageal toxicity was
much rarer than acute toxicity in the series of Maguire et al.
(18%), with grade 3 toxicity (requiring dilatation) developing
in only 3% of patients. The incidence of severe late toxicity
seems to be increased when chemotherapy and radiotherapy
[21] are used together.
According to DR Camidge, ‘‘symptomatic acute radiation
oesophagitis usually develops 2 or 3 weeks after the beginning
of treatment and may last for several months’’ [13]. In the Kaa-
sa study, only 22% of patients still experienced dysphagia
8 weeks after treatment. This concurs with the assessment of
Kaplinski et al.: ‘‘The incidence of late radiation injury of
the oesophagus is not precisely determined but, overall, the
occurrence of clinically apparent damage is infrequent’’ [15].
Dysphagia due to secondary achalasia
In the present case, the diagnosis was made when the tumour
caused haemoptysis and hoarseness of voice, however, dyspha-
gia and hoarseness of voice in patients with lung cancer
are usually suggestive of mediastinal spread of the tumour.
Symptoms due to mediastinal spread are particularly common
in patients with small cell carcinoma because of the high
frequency with which this histologic type spreads to the
mediastinum and because involved nodes tend to be bulky in
comparison with mediastinal involvement by other histological
types [22,23].
We found no evidence of mediastinal lymph node enlarge-
ment or direct tumour invasion of the oesophagus and dyspha-
gia was found to be due to oesophageal achalasia. Clinical
features of idiopathic achalasia closely mimic secondary acha-
lasia, and can have the same manometric features [23]. How-
ever, it is likely that dysphagia in the present case was due to
secondary achalasia as patients with secondary achalasia tend
to be older (>50 years), to have shorter duration of dysphagia
(<1 year) and to have greater weight loss when compared to
those with idiopathic achalasia [24]. In most cases secondary
achalasia has been reported due to oesophageal obstruction
caused by tumour inﬁltration or encasement of the oesophag-
ogastric junction. Other suggested explanations include physi-
cal disruption of the myenteric plexus by the tumour and
deposition of eosinophilic cationic protein associated with
the tumour causing damage to the myenteric plexus [25,26].
Intestinal motility disorders in small cell lung cancer have been
reported due to paraneoplastic enteric neuropathy linked to
the presence of antineuronal antibody (also known as anti-
hu antibody) [27]. In the present case dysphagia due to second-
ary achalasia was an early feature of central airway squamous
cell carcinoma, probably caused by inﬁltration of the myen-
teric plexus by the tumour. Secondary achalasia due to squa-
mous cell carcinoma of central airways should be considered
in patients with dysphagia without an obvious cause.Dysphagia due to oropharyngeal and oesophageal candidal
infections
Candidal infections are common in cancer patients [28].
Although a well recognized complication of leukaemias and
lymphomas (or their treatment), oesophageal candidiasis is less
often associated with lung cancer [29].They are usually obvious
clinically but seldom cause enough oropharyngeal discomfort
to limit intake [28]. Viral and bacterial stomatitis and oesoph-
agitis can occur in the lung cancer population but they are suf-
ﬁciently rare that additional risk factors, such as underlying
HIV infection, should probably be sought [30]. Abnormal
oesophageal motility (due to obstruction or achalasia) may
be a predisposing factor [29], as may be use of corticosteroids,
antibiotics or radiotherapy [27]. The deﬁnitive diagnosis of
oesophageal candida rests on oesophagoscopy and biopsy
[28], but in practice antifungal agents such as ﬂuconazole are
often used empirically.
Conclusion
Dysphagia associated with bronchogenic carcinoma is not
uncommon and should be asked for and documented in all
cases if present. Secondary achalasia is the commonest mecha-
nism of dysphagia based on oesphagoscopy and manometry.
Further large sample multicenteric studies are needed to out-
line a proper management plan for dysphagia in lung cancer
in collaboration with the gastroenterology medical and surgi-
cal departments.
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